4//SEC Filing
Bogle Grant C. 4
Accession 0000899243-22-011729
CIK 0001571498other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 6:06 PM ET
Size
5.5 KB
Accession
0000899243-22-011729
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Bogle Grant C.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-17+800,000→ 800,000 totalExercise: $1.39Exp: 2032-03-16→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]This option was granted on March 17, 2022 pursuant to the Company's 2013 Stock Incentive Plan with respect to 800,000 shares of Common Stock, with 25% vesting on March 17, 2023 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Epizyme, Inc.
CIK 0001571498
Entity typeother
Related Parties
1- filerCIK 0001646675
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 6:06 PM ET
- Size
- 5.5 KB